2Harada K, Friedman M, Lopez JJ, et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol, 1996; 270 (5):1791.
3Rosengart K , Lee LY , Petel SR , et al. Angiogenesis gene therapy t Phase I assessment of direct intyanyocardial administration of an adenovirus vector expressing VEGFIn. cDNA to individuals with clinically significant severe coronary artery disease. Circulation, 1999 ; 100(5): 468.
4Kumar H, Heer K ,Lee PW,et al. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin CancerRes,1998;4(5) : 1279.
6Masood R, Cai J, Zheng T, et al. Vascular endothelial growth factor/vascular permeability factor isan autocrine growth factor for AIDS-kaposi sarcoma. Proc Natl Acad Sci USA,1997;94(3) : 979.
7Kamiyama M, Ichikawa Y, Ishikawa T, et al. VEGF receptor antisense therapy inhibits angiogenesis and peritoneal dissemination of human gastric cancer in nude mice. Cancer Gene Ther, 2002 ; 9 (2) : 197.
8Nelson NJ. Inhibitors of angiogenesis enter phase Ⅱ testing . J Natl Cancer Inst,1998;90(13) : 960.
9Prewett M, Huber J, Li Y, et al. Antivascular endothelial growth factor receptor ( fetal liver kinasel ) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumonfrs. Cancer Res, 1999 ; 59 (20) : 5209.
4Pareek G, Shevchuk M, Armenakas NA,. Vasjovic L, Hochberg DA, Basillote JB, Fracchia JA. The effect of finastefide on the expression of vascular endothelial growth factor and microvessel density : a possible mechanism for decreased prostatic bleeding in treated patients. J Urol,2003,169 ( 1 ) : 20 - 23.
5Yang J , Wu HF , Qian LX,et al. Increased expressions of vascular endothelial growth factor ( VEGF ) , VEGF - C and VEGF receptor -3 in prostate cancer tissue are associated with tumor progression. Asian J Androl ,2006,8(2) :169 - 175.
6Richard C, Kim G, Koikawa Y, et al. Androgens modulate the balance between VEGF and angiopoiet in expression in prostate epithelial and smooth musclecells. Prostate,2002,50 ( 2 ) : 83 - 91.
7Kwak C, Jin R J, Lee C, et al. Thrombospondin - 1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia. BJU Int, 2002, 89(3) : 303 -309.
8CEVTKOVIC D , MOVSAS B ,DICKER A P ,et al . Increased Hypoxia Correlates with Increased Expression of the Angiogenesis Marker Vascular Endothelial Growth Factor in Human Prostate Cancer. Urology,2001,57(4) :821 -825.
9Hatva E, Kaipainen A, Mentula P, et al. Expression of endothelial cell specific receptor tyrosine kinase and growth factors in human brain tumors. AmJ Pathol ,1994 ,146 (2) :368 -378.
